Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for treating solid cancers. Its Alpha DaRT technology is in clinical trials for skin, oral, pancreatic, prostate, lung, liver, and breast cancers, and in preclinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for prostate cancer treatment. It is headquartered in Jerusalem, Israel.